Matthias Holdhoff

18.8k total citations
111 papers, 2.1k citations indexed

About

Matthias Holdhoff is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthias Holdhoff has authored 111 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Genetics, 29 papers in Oncology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthias Holdhoff's work include Glioma Diagnosis and Treatment (72 papers), Brain Metastases and Treatment (20 papers) and CNS Lymphoma Diagnosis and Treatment (16 papers). Matthias Holdhoff is often cited by papers focused on Glioma Diagnosis and Treatment (72 papers), Brain Metastases and Treatment (20 papers) and CNS Lymphoma Diagnosis and Treatment (16 papers). Matthias Holdhoff collaborates with scholars based in United States, Germany and Spain. Matthias Holdhoff's co-authors include Stuart A. Grossman, Luis A. Díaz, Xiaobu Ye, Jaishri O. Blakeley, Shibin Zhou, Nicholas J. Roberts, Chetan Bettegowda, Prakash Ambady, David Bonekamp and Charles G. Eberhart and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Matthias Holdhoff

100 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Holdhoff United States 27 821 604 596 370 348 111 2.1k
Sridhar Epari India 23 783 1.0× 288 0.5× 599 1.0× 304 0.8× 360 1.0× 198 1.9k
Edward Pan United States 26 881 1.1× 388 0.6× 709 1.2× 235 0.6× 368 1.1× 79 1.9k
Sofia Haque United States 28 391 0.5× 939 1.6× 747 1.3× 373 1.0× 461 1.3× 95 2.5k
Pierre-Yves Dietrich Switzerland 13 1.5k 1.8× 624 1.0× 942 1.6× 197 0.5× 536 1.5× 14 2.5k
Seema Nagpal United States 27 1.0k 1.2× 828 1.4× 432 0.7× 308 0.8× 1.1k 3.1× 129 2.8k
Benoît Lhermitte France 18 1.1k 1.4× 710 1.2× 821 1.4× 187 0.5× 702 2.0× 77 2.5k
H. S. Friedman United States 21 969 1.2× 627 1.0× 907 1.5× 454 1.2× 625 1.8× 50 2.4k
Sophie Camilleri‐Broët France 28 497 0.6× 944 1.6× 611 1.0× 599 1.6× 460 1.3× 82 2.5k
R. Rampling United Kingdom 19 1.3k 1.6× 500 0.8× 565 0.9× 216 0.6× 681 2.0× 30 2.1k
Christopher E. Pelloski United States 17 847 1.0× 532 0.9× 1.1k 1.8× 146 0.4× 439 1.3× 35 2.2k

Countries citing papers authored by Matthias Holdhoff

Since Specialization
Citations

This map shows the geographic impact of Matthias Holdhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Holdhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Holdhoff more than expected).

Fields of papers citing papers by Matthias Holdhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Holdhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Holdhoff. The network helps show where Matthias Holdhoff may publish in the future.

Co-authorship network of co-authors of Matthias Holdhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Holdhoff. A scholar is included among the top collaborators of Matthias Holdhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Holdhoff. Matthias Holdhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rogers, James L., Chad A. Caraway, Ali Ahmed, et al.. (2025). Clinical Outcome Assessment Tools for Evaluating the Management of Gliomas. Cancers. 17(10). 1659–1659.
2.
3.
Rizk, Emanuelle M., Mohamed Sherief, Michael Chang, et al.. (2024). Molecular characterization of gliosarcoma reveals prognostic biomarkers and clinical parallels with glioblastoma. Journal of Neuro-Oncology. 171(2). 403–411.
4.
5.
Sloan, Lindsey, Rupashree Sen, Michèle Doucet, et al.. (2024). Radiation immunodynamics in patients with glioblastoma receiving chemoradiation. Frontiers in Immunology. 15. 1438044–1438044. 3 indexed citations
6.
Komlódi-Pásztor, Edina, Marcus Messmer, Richard F. Ambinder, et al.. (2024). The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment. Frontiers in Immunology. 15. 1433442–1433442. 1 indexed citations
7.
Mellon, Eric A., Mohammed Goryawala, Peter B. Barker, et al.. (2023). A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma. Tomography. 9(1). 362–374. 2 indexed citations
8.
Downs, Bradley M., Leslie Cope, Christopher B. Umbricht, et al.. (2021). Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors. Clinical Epigenetics. 13(1). 104–104. 12 indexed citations
9.
Holdhoff, Matthias, Nina D. Wagner‐Johnston, & Mark Roschewski. (2020). Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Ye, Xiaobu, Omar Dzaye, Nina D. Wagner‐Johnston, et al.. (2019). White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab. Journal of Neuro-Oncology. 145(3). 461–466. 11 indexed citations
11.
Jiang, Shanshan, Charles G. Eberhart, Michael Lim, et al.. (2018). Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy. Clinical Cancer Research. 25(2). 552–561. 114 indexed citations
12.
Holdhoff, Matthias. (2018). Role of Molecular Pathology in the Treatment of Anaplastic Gliomas and Glioblastomas. Journal of the National Comprehensive Cancer Network. 16(5S). 642–645. 4 indexed citations
13.
Menke, Joshua, Matthias Holdhoff, John Laterra, et al.. (2017). Prostate-Specific Membrane Antigen–Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas. Clinical Nuclear Medicine. 42(10). e433–e435. 52 indexed citations
14.
Holdhoff, Matthias, Güneş Güner, Fausto J. Rodríguez, et al.. (2016). Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization. Clinical Cancer Research. 23(12). 3150–3157. 52 indexed citations
15.
Staedtke, Verena, Omar Dzaye, & Matthias Holdhoff. (2016). Actionable Molecular Biomarkers in Primary Brain Tumors. Trends in cancer. 2(7). 338–349. 36 indexed citations
16.
Rodón, Jordi, Michael A. Carducci, Juan Manuel Sepúlveda-Sánchez, et al.. (2014). First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma. Clinical Cancer Research. 21(3). 553–560. 200 indexed citations
17.
Azaro, Analía, Jordi Rodón, Michael A. Carducci, et al.. (2014). Case Series of Cancer Patients Treated With Galunisertib, a Transforming Growth Factor-Beta Receptor I Kinase Inhibitor in a First-in-Human Dose Study. Journal of Medical Cases. 5(11). 603–609. 1 indexed citations
18.
Korley, Frederick K., et al.. (2014). Evaluation of Eight Plasma Proteins as Candidate Blood-Based Biomarkers for Malignant Gliomas. Cancer Investigation. 32(8). 423–429. 21 indexed citations
19.
Holdhoff, Matthias, et al.. (2013). Blood-based biomarkers for malignant gliomas. Journal of Neuro-Oncology. 113(3). 345–352. 34 indexed citations
20.
Holdhoff, Matthias, Kerstin Schmidt, Frank Diehl, et al.. (2011). Detection of Tumor DNA at the Margins of Colorectal Cancer Liver Metastasis. Clinical Cancer Research. 17(11). 3551–3557. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sridhar Epari Breakdown of academic impact, for papers by Edward Pan Breakdown of academic impact, for papers by Sofia Haque Breakdown of academic impact, for papers by Pierre-Yves Dietrich Breakdown of academic impact, for papers by Seema Nagpal Breakdown of academic impact, for papers by Benoît Lhermitte Breakdown of academic impact, for papers by H. S. Friedman Breakdown of academic impact, for papers by Sophie Camilleri‐Broët Breakdown of academic impact, for papers by R. Rampling Breakdown of academic impact, for papers by Christopher E. Pelloski
Rankless by CCL
2026